SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
QuidelOrtho Corporation QDEL recently announced that its TriageTrue High-Sensitivity Troponin I (hsTnl) Test on the Quidel Triage MeterPro had been approved for use in Canada by Health Canada. Per the ...
QuidelOrtho is recalling thousands of blood tests used to help quickly diagnose myocardial infarctions and other heart conditions. The company began recalling certain lots of the Quidel Triage Cardiac ...
Nearly 8,000 cardiac panel blood tests have been recalled after 41 reports of inaccurate test results that pose the risk of missing a heart attack diagnosis, the FDA said July 17. Quidel ...
Please provide your email address to receive an email when new articles are posted on . Certain blood tests have been recalled due to risk for false negative or falsely low cardiac troponin levels.
Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results